These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 8621903)

  • 21. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
    Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI
    Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes.
    Schirmbeck R; Zerrahn J; Kuhröber A; Deppert W; Reimann J
    Eur J Immunol; 1993 Jul; 23(7):1528-34. PubMed ID: 8325328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
    Yang BF; Zhao HL; Xue C; Xiong XH; Zhang W; Yao XQ; Liu ZM
    Vaccine; 2007 May; 25(22):4478-86. PubMed ID: 17467856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice.
    Tindle RW; Herd K; Londoño P; Fernando GJ; Chatfield SN; Malcolm K; Dougan G
    Virology; 1994 May; 200(2):547-57. PubMed ID: 7513919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro expansion distorts the detectable pattern of specific recognition of in vivo primed cytotoxic T lymphocyte populations.
    Schirmbeck R; Deppert W; Kury E; Reimann J
    Cell Immunol; 1993 Jul; 149(2):444-9. PubMed ID: 8330320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
    Vasilakos JP; Michael JG
    J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L; Tian YJ; Shen H; Zhao XP; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunogenicity of new DNA vaccine encoding for hepatitis B virus core antigen].
    Xing YP; Huang ZH; Wang SX; Cai J; Li J; Lu S
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):338-40. PubMed ID: 15225426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y; Guidotti LG; Fowler P; Chisari FV
    J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells.
    Schirmbeck R; Reimann J
    Biol Chem; 1999 Mar; 380(3):285-91. PubMed ID: 10223330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region.
    Street M; Herd K; Londono P; Doan T; Dougan G; Kast WM; Tindle RW
    Arch Virol; 1999; 144(7):1323-43. PubMed ID: 10481740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.
    Milich DR; McLachlan A; Moriarty A; Thornton GB
    J Immunol; 1987 Aug; 139(4):1223-31. PubMed ID: 2440947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.
    Livingston BD; Crimi C; Grey H; Ishioka G; Chisari FV; Fikes J; Grey H; Chesnut RW; Sette A
    J Immunol; 1997 Aug; 159(3):1383-92. PubMed ID: 9233635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.
    Sällberg M; Townsend K; Chen M; O'Dea J; Banks T; Jolly DJ; Chang SM; Lee WT; Milich DR
    J Virol; 1997 Jul; 71(7):5295-303. PubMed ID: 9188598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single B or T-cell epitope-based DNA vaccine using modified vector induces specific immune response against hepadnavirus.
    Xu HB; Xu W; Chu YW; Wang Y; Xiong S
    Immunol Lett; 2005 Jul; 99(2):186-92. PubMed ID: 16009269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence.
    Milich DR; Chen MK; Hughes JL; Jones JE
    J Immunol; 1998 Feb; 160(4):2013-21. PubMed ID: 9469465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.
    Takashima H; Araki K; Miyazaki J; Yamamura K; Kimoto M
    Immunology; 1992 Mar; 75(3):398-405. PubMed ID: 1533387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.